多基因风险评分与慢阻肺诊断年龄的关联
研究基于COPDGene和FHS队列,检验慢阻肺多基因风险评分(PRS)与诊断年龄的关系。PRS与年轻时发病风险增加相关,且在不同种族中均对50岁前诊断有预测价值,加入已知早发风险因素后预测能力提升。
要点
- PRS与慢阻肺诊断年龄提前相关,年轻人群效应更大。
- PRS对50岁前诊断的OR在NHW为1.55,AA为1.23,FHS为2.47。
- PRS加入早期风险因素可改善50岁前诊断预测(AUC提升)。
核心结论
- 慢阻肺PRS与更早的诊断年龄相关,且在已知早发风险因素基础上仍具预测价值。
研究设计与样本
- 研究纳入COPDGene中6647名非西班牙裔白人和2464名非洲裔美国人,以及FHS中6812名参与者。
- 采用Cox回归分析PRS对慢阻肺发病的整体和时间依赖性效应。
- 在COPDGene中使用逻辑回归和AUC分析评估PRS对50岁前慢阻肺的预测价值。
主要发现
- PRS与 incident COPD 的关联呈年龄依赖性,年轻年龄效应更大。
- PRS与50岁前慢阻肺相关:NHW OR 1.55(95% CI 1.41-1.71),AA OR 1.23(95% CI 1.05-1.43),FHS OR 2.47(95% CI 2.12-2.88)。
- 在COPDGene中,PRS加入已知早发风险因素后,NHW的AUC从0.69升至0.74(p<0.0001),AA从0.61升至0.64(p=0.04)。
临床怎么用
- PRS可能辅助识别慢阻肺早发高风险人群,尤其是在结合早期风险因素时。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Genetic susceptibility may be associated with earlier onset of chronic obstructive pulmonary disease (COPD). We hypothesised that a polygenic risk score (PRS) for COPD would be associated with earlier age of diagnosis of COPD. METHODS: In 6647 non-Hispanic White (NHW) and 2464 African American (AA) participants from COPDGene, and 6812 participants from the Framingham Heart Study (FHS), we tested the relationship of the PRS and age of COPD diagnosis. Age at diagnosis was determined by: 1) self-reported age at COPD diagnosis or 2) age at visits when moderate-to-severe airflow limitation (Global Initiative for Chronic Obstructive Lung Disease (GOLD) grade 2-4) was observed on spirometry. We used Cox regression to examine the overall and time-dependent effects of the PRS on incident COPD. In the COPDGene study, we also examined the PRS's predictive value for COPD at age <50 years (COPD50) using logistic regression and area under the curve (AUC) analyses, with and without the addition of other risk factors present at early life (e.g. childhood asthma). RESULTS: In Cox models, the PRS demonstrated age-dependent associations with incident COPD, with larger effects at younger ages in both cohorts. The PRS was associated with COPD50 (OR 1.55 (95% CI 1.41-1.71) for NHW, OR 1.23 (95% CI 1.05-1.43) for AA and OR 2.47 (95% CI 2.12-2.88) for FHS participants). In COPDGene, adding the PRS to known early-life risk factors improved prediction of COPD50 in NHW (AUC 0.69 versus 0.74; p<0.0001) and AA (AUC 0.61 versus 0.64; p=0.04) participants. CONCLUSIONS: A COPD PRS is associated with earlier age of diagnosis of COPD and retains predictive value when added to known early-life risk factors.
引用
- Zhang J, Xu H, Qiao D, et al. A polygenic risk score and age of diagnosis of COPD. Eur Respir J. 2022. PMID: 35115341. doi:10.1183/13993003.01954-2021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。